“Real-World Patient Perspectives on Glipizide and Empagliflozin for Type 2 Diabetes: Glipizide Vs Empagliflozin”. Journal of Diabesity, vol. 1, no. 1, Oct. 2025, p. 9, https://doi.org/10.66381/jod.2025.005.